GlassScriptPhysician profile
Daniel Feldman Elmes
NPI 1316500994
$8,344.51
in general payments reported to CMS, 2019-2025
11 companies · $1,768 in 2025
The $1,768 reported for 2025 was more than what 89% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.03 · 2021: $2,592 · 2022: $2,388 · 2023: $138 · 2024: $1,429 · 2025: $1,768.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,883 · Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,882.50 |
| Food and Beverage | $452.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $2,429.00 | 2021 | |
| Stryker Corporation | $2,256.01 | 2022-2024 | Prostep, Prostep Mica, Citrefix |
| Enduromed, LLC | $1,467.81 | 2024-2025 | |
| Great Lakes Orthopedics | $1,200.00 | 2022 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Smith+Nephew, INC. | $279.22 | 2021-2022 | |
| Acumed LLC | $140.00 | 2022 | |
| Organogenesis INC. | $138.36 | 2023 | Puraply |
| Orthofix Medical, INC. | $75.97 | 2022-2025 | Physio-Stim |
| Triad Life Sciences INC. | $40.91 | 2022 | |
| Horizon Therapeutics Plc | $29.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Elmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.